
Turning Point Brands (TPB) has drawn attention after a sharp share price move, with the stock down about 38% over the past month and 20% in the past 3 months.
See our latest analysis for Turning Point Brands.
The recent 38.2% one-month share price decline comes after a strong one-year total shareholder return of 43.9% and a very large three-year total shareholder return. This suggests that momentum has cooled even though longer-term holders remain well ahead.
If this kind of sharp swing has you rethinking your watchlist, it can help to scan for other ideas with different drivers, including 20 top founder-led companies
With TPB now trading well below its recent highs but still showing solid reported revenue and net income growth, the key question is simple: is this a mispriced value opportunity, or is the market already baking in future gains?
With Turning Point Brands last closing at $84.56 and the most followed narrative pointing to a fair value of $132.50, the current pullback sits against a backdrop of higher implied value and ambitious growth assumptions.
The company's ability to grow its premium brands in high-margin niches (e.g., Stoker's MST and Zig-Zag) while maintaining strong customer loyalty and executing pricing actions, even as legacy segments decline, underpins stable or improving net margins and cash generation through industry transitions.
Want to see what earnings trajectory sits behind that margin story? The narrative leans on rapid top line expansion, fatter margins, and a future earnings multiple that assumes this growth engine keeps firing.
Result: Fair Value of $132.50 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, keep in mind that heavier trade spend and any tougher regulation or taxation on modern oral products could quickly challenge those upbeat margin and growth assumptions.
Find out about the key risks to this Turning Point Brands narrative.
That 36.2% “undervalued” narrative sits alongside a more cautious picture when you look at simple pricing. TPB trades on a P/E of 28.1x, compared with a global Tobacco average of 12.6x, a peer average of 30.7x, and a fair ratio of 26.1x, which points to some valuation stretch if the story stumbles.
Before leaning too hard on any one price tag, it can help to stress test the earnings assumptions behind it and see what the numbers imply for downside as well as upside, then ask whether this premium is really one you are comfortable paying over time. See what the numbers say about this price — find out in our valuation breakdown.
With sentiment around TPB clearly mixed, this is a good time to look under the hood yourself and pressure test the numbers and narratives quickly. To see what is driving the optimism and weigh those potential rewards against the risks, check the 4 key rewards
If TPB has you rethinking your next move, do not stop here. Use data driven stock lists to quickly surface alternatives that better match your goals.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com